Loading…

BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: Correlation with biological and clinical features

Abstract B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tested intracellular BAFF and APRIL expressi...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia research 2009-10, Vol.33 (10), p.1319-1327
Main Authors: Bojarska-Junak, Agnieszka, Hus, Iwona, Chocholska, Sylwia, Wąsik-Szczepanek, Ewa, Sieklucka, Małgorzata, Dmoszyńska, Anna, Roliński, Jacek
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tested intracellular BAFF and APRIL expression in B-CLL and evaluated their prognostic relevance. The percentage of leukemic B cells with intracellular APRIL or BAFF expression correlated significantly with adverse prognostic factors such as ZAP-70 and CD38. Moreover, we found a close relationship between LPL protein expression or LPL/ADAM29 MFI ratio and proportion of B-CLL cells with intracellular BAFF or APRIL expression. Furthermore, patients with a low percentage of leukemic cells with intracellular BAFF or APRIL expression had a significantly longer overall survival than those with a high proportion of APRIL or BAFF positive leukemic cells.
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2009.03.030